General Information
Revision date
2021-10-19
Product name
NIMBEX SOLUTION
Product Synonyms
CISATRAC * CISATRAC FORTE * NIMBEX SOLUTION FOR INJECTION/INFUSION (2 MG/ML, 5 MG/ML,10 MG/ML) * NIMBEX 5 * NIMBEX FORTE * NIMBEX FORTE SOLUTION FOR
Icons in SDS
Company Information
company name
Tianjin SmithKline (GSK) Laboratory Co. Ltd.
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Emergency overview Caution - Pharmaceutical agent. Causes serious eye irritation. Causes skin irritation. See section 11 of the SDS for additional information on health hazards.
Hazard statements
categories H315 Causes skin irritation. H319 Causes serious eye irritation.
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2A Causes skin irritation. Causes serious eye irritation. See section 11 of the SDS for additional information on health hazards.
Environmental hazards
Not classified. The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.
Signal word
Warning
Prevention
P264 Wash hands thoroughly after handling. P280 Wear eye protection/face protection. P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
None.
Disposal
None.
Other physicochemical hazards
The product is stable and non-reactive under normal conditions of use, storage and transport. No unusual fire or explosion hazards noted.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
2.25 % of the mixture consists of component(s) of unknown acute dermal toxicity. 1.2 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 1.2 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
